Bank of New York Mellon
TMCI icon

Bank of New York Mellon’s Treace Medical Concepts TMCI Stock Holding History

Bank of New York Mellon’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-121,020
Closed -$162K – 4431
2026
Q1 		$162K Hold
121,020
– – ﹤0.01% 4043
2025
Q4 		$296K Sell
121,020
-1,932
-2% -$8.39K ﹤0.01% 3864
2025
Q3 		$825K Buy
122,952
+1,539
+1% +$10K ﹤0.01% 3324
2025
Q2 		$714K Sell
121,413
-904
-0.7% -$5.89K ﹤0.01% 3312
2025
Q1 		$1.03M Sell
122,317
-3,628
-3% -$32.6K ﹤0.01% 3054
2024
Q4 		$937K Buy
125,945
+3,215
+3% +$21.5K ﹤0.01% 3203
2024
Q3 		$712K Sell
122,730
-38,683
-24% -$248K ﹤0.01% 3319
2024
Q2 		$1.07M Buy
161,413
+18,721
+13% +$151K ﹤0.01% 3159
2024
Q1 		$1.86M Sell
142,692
-14,945
-9% -$199K ﹤0.01% 2800
2023
Q4 		$2.01M Sell
157,637
-8,713
-5% -$88K ﹤0.01% 2834
2023
Q3 		$2.18M Buy
166,350
+3,051
+2% +$55.8K ﹤0.01% 2765
2023
Q2 		$4.18M Buy
163,299
+39,645
+32% +$1.02M ﹤0.01% 2420
2023
Q1 		$3.11M Sell
123,654
-5,171
-4% -$121K ﹤0.01% 2552
2022
Q4 		$2.96M Buy
128,825
+27,443
+27% +$632K ﹤0.01% 2633
2022
Q3 		$2.24M Buy
101,382
+21,089
+26% +$408K ﹤0.01% 2773
2022
Q2 		$1.15M Buy
80,293
+2,641
+3% +$44.5K ﹤0.01% 3145
2022
Q1 		$1.47M Buy
77,652
+4,156
+6% +$80.8K ﹤0.01% 3096
2021
Q4 		$1.37M Buy
73,496
+41,409
+129% +$855K ﹤0.01% 3205
2021
Q3 		$863K Buy
32,087
+6,222
+24% +$171K ﹤0.01% 3477
2021
Q2 		$808K Buy
+25,865
New +$823K ﹤0.01% 3542

Other funds holding TMCI

GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AWMNY
Arcadia Wealth Management (New York) Smithtown, New York $210M AUM 25.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LS
LCW Services Virginia Beach, Virginia $230M AUM
VPIM
Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return

Bank of New York Mellon's TMCI Position: Q2 2026 in Review

Bank of New York Mellon sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 121,020 shares — an estimated $162K sold.

Bank of New York Mellon first reported a position in TMCI in Q2 2021 and held it in 20 quarters. The position peaked at $4.18M in Q2 2023. 51 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Bank of New York Mellon reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
  • Bank of New York Mellon sold 121,020 Treace Medical Concepts shares in Q2 2026, an estimated $162K.
  • Bank of New York Mellon first reported a position in Treace Medical Concepts in Q2 2021 and held it in 20 quarters.
  • Bank of New York Mellon's Treace Medical Concepts position peaked at $4.18M in Q2 2023.
  • 51 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.